In Brief: J&J Regranex
Executive Summary
J&J Regranex: Becaplermin gel .01% will first be marketed only in 15 g tubes; FDA also approved 2 g and 7.5 g tubes of the platelet-derived growth factor for diabetic ulcers on Dec. 16 ("The Pink Sheet" Dec. 22, p. 4)...